Literature DB >> 24497874

Comparison of HCV prevalence in pakistan and iran; an insight into future.

Muhammad Sohail Afzal1, Tahir Ahmed1, Najam Us Sahar Sadaf Zaidi1.   

Abstract

Entities:  

Keywords:  Awareness; Health Promotion; Hepatitis C; Infection; Prevalence

Year:  2014        PMID: 24497874      PMCID: PMC3909635          DOI: 10.5812/hepatmon.11466

Source DB:  PubMed          Journal:  Hepat Mon        ISSN: 1735-143X            Impact factor:   0.660


× No keyword cloud information.
Dear Editor, A recent report by Shakeri et al. (March, 2013) published in Hepatitis Monthly showed that HCV prevalence is 0.2% in Mashad, Iran (1). Moreover, Previous report from Iran showed the similar prevalence of HCV in voluntaries blood donors (2). Pakistan, a neighboring country of Iran, is a low socioeconomic country having more than 10 million HCV infected people (3). Recently we have published the prevalence of HCV among 62,251 healthy blood donors from North West Province of Pakistan. The study showed that 2.6 % of healthy individuals were HCV antibody positive (4). We also concluded that the HCV prevalence is increasing with time when the results were compared with other previous reports. HCV with more than 180 million infections worldwide (5), can lead to chronic infection and hepatocellular carcinoma (HCC) in 60% to 80% of infected individuals (6). Genetic differences among different ethnic groups results in differential susceptibility of infection and 20 % of infected individuals can clear the virus naturally due to their genetic makeup (7, 8). Better understanding of genetic factors, which are differentially distributed among different ethnic groups and have effect on hepatitis C susceptibility, progression, pathogeneses, would provide a scientific basis for HCV differential prevalence. Complete understanding the underlying molecular mechanisms involved in immune regulation in HCV infected patients will help in the development of new immunomodulatory treatments. Currently there is no vaccine available to control HCV largely due to its unpredictable genomic variations. As Pakistani population is more affected with this deadly virus, a large proportion of infected individuals are in danger of developing cirrhosis and hepatocellular carcinoma. In Iran, the situation in not alarming currently but there is a need to conduct the continuous and regular prevalence studies on larger scale. As the incidence of HCV infection in Pakistan is increasing with time, the HCV prevalence studies are recommended in Iran on regular intervals to estimate the actual infection rate of HCV. Massive awareness campaigns are also needed to educate the general population about the roots of HCV spread and prevention methods to contain the deadly virus spread. It is observed that barbers and dentists are the major cause of viral spread in healthy population. Therefore, it is necessary to educate the barbers and dentists in Iran and their practices should be supervised more efficiently according to HCV safety protocols.
  6 in total

1.  Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study.

Authors:  Seyed Moayed Alavian; Bardia Gholami; Sadegh Masarrat
Journal:  J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 4.029

2.  Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.

Authors:  Muhammad Sohail Afzal; Sadia Tahir; Amna Salman; Tahir Ahmed Baig; Talha Shafi; Najm Us Sahar Sadaf Zaidi; Ishtiaq Qadri
Journal:  J Infect Dev Ctries       Date:  2011-07-04       Impact factor: 0.968

3.  The prevalence of hepatitis C virus in mashhad, iran: a population-based study.

Authors:  Mohammad Taghi Shakeri; Hosein Nomani; Majid Ghayour Mobarhan; Hamid Reza Sima; Sina Gerayli; Shirin Shahbazi; Sina Rostami; Zahra Meshkat
Journal:  Hepat Mon       Date:  2013-03-12       Impact factor: 0.660

4.  Sequence and structural analysis of 3' untranslated region of hepatitis C virus, genotype 3a, from pakistani isolates.

Authors:  Sadia Anjum; Sidra Ali; Tahir Ahmad; Muhammad Sohail Afzal; Yasir Waheed; Talha Shafi; Muhammad Ashraf; Saadia Andleeb
Journal:  Hepat Mon       Date:  2013-05-09       Impact factor: 0.660

5.  Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in.

Authors:  Yasir Waheed; Umar Saeed; Sadia Anjum; Mohammad Sohail Afzal; Muhammad Ashraf
Journal:  Hepat Mon       Date:  2012-09-25       Impact factor: 0.660

6.  Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-α Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population.

Authors:  Muhammad Sohail Afzal; Sadia Anjum; Najam Us Sahar Sadaf Zaidi
Journal:  Hepat Mon       Date:  2013-06-08       Impact factor: 0.660

  6 in total
  7 in total

1.  Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and Ribavirin.

Authors:  Fahimeh Safarnezhad Tameshkel; Mohammad Hadi Karbalaie Niya; Msuodreza Sohrabi; Mahshid Panahi; Farhad Zamani; Farid Imanzade; Nasser Rakhshani
Journal:  Iran J Pathol       Date:  2016

2.  Diagnostically untypable hepatitis C virus variants: it is time to resolve the problem.

Authors:  Muhammad Sohail Afzal; Muhammad Yousaf Khan; Muhammad Ammar; Sadia Anjum; Najm Us Sahar Sadaf Zaidi
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective.

Authors:  Muhammad Sohail Afzal
Journal:  World J Hepatol       Date:  2016-09-18

4.  Hepatitis C virus capsid protein and intracellular lipids interplay and its association with hepatic steatosis.

Authors:  Muhammad Sohail Afzal; Najam Us Sahar Sadaf Zaidi; Jean Dubuisson; Yves Rouille
Journal:  Hepat Mon       Date:  2014-08-11       Impact factor: 0.660

Review 5.  Emerging and re-emerging infectious diseases in Iran.

Authors:  Najmeh Parhizgari; Mohammad Mehdi Gouya; Ehsan Mostafavi
Journal:  Iran J Microbiol       Date:  2017-06

6.  Changing of HCV clade pattern in iran; the possible means for something good.

Authors:  Muhammad Sohail Afzal; Sadia Anjum; Najam Us Sahar Sadaf Zaidi
Journal:  Hepat Mon       Date:  2014-01-06       Impact factor: 0.660

7.  Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures.

Authors:  Muhammad Sohail Afzal; Tahir Ahmad; Haroon Ahmed
Journal:  Hepat Mon       Date:  2015-10-24       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.